Perinatal infections Flashcards
Parvovirus risk of infection in pregnancy by exposure location
20% if at home
8-12% at childcare
8% in community
Outcomes with proven maternal infection of Parvo
10% miscarriage
3% hydrops - 1/3 resolve, 1/3 IUT, 1/3 die without IUT
<1% congenital abnormalities
Monitoring in recent parvo infection
USS at 1-2 weekly intervals for 12 weeks
If no fetal abnormality noted after 30 weeks - stop scanning
anaemia - refer MFM for IUT
Positive Syphilis
VDRL +ve
RPR titre +ve
TPPA +ve
Latent infection/past treated Syphilis
VDRL -ve
RPR -ve
+ve TPPA
Possible false positive or early infection syphilis
VDRL +
RPR +
- TPPA
Repeat test in 4 weeks
Syphilis stage and risk of infection
Primary (chancre)-high
Secondary (systemic illness)-Moderate
Latent and tertiary - neglibile
Management of Syphilis
Treat with Benzathine Penicillin 1.8g
MDT with infectious diseases and paediatric team
Monthly RPR and VDRL until delivery
-if _ve or >4 fold drop in titre - successful tx
-retreat if rise in titre
CMV risk of fetal infection by primary or secondary infection
primary:30% chance of fetal infection
30% chance of fetus being affected
Non-primary: approx 1%
risk of sequelae with CMV symptomatic or asymptomatic infection
Primary: symptomatic 50%
asymptomatic 10-15%
Secondary: <10%
CMV testing - recent infection
+igG
+IgM
low avidity
if intermediate avidity - treat as recent infection
CMV management
Fetal USS (6 weeks after maternal infection) - CNS signs, hydrops, echogenic bowel, IUGR
Fetal MRI-microcephaly
Amnio-higher sensitivity if after 20 weeks
If woman immunocompromised can do valaciclovir
Fetal risks with CMV infection
CP
Sensorineural hearing loss
Visual impairment
Delayed psychomotor development
Secondary herpes infection risk of transmission
<1%if no active disease
1-3% if HSV in genital tract at time of delivery
(higher risk if recurrent HSV 1 (15%) than HSV 2 (<0.01%)
Primary herpes with no seroconversion before 34 weeks risk of transmission
25-50%